
|Articles|December 29, 2015
State of the healthcare industry survey results
Author(s)Aubrey Westgate
Here's how more than 600 healthcare executives responded to questions related to reimbursement, pharmaceuticals, consumerism, consolidation, technology, and more.
Advertisement
State of the Industry Survey Results
Here's how more than 600 healthcare executives responded to questions related to reimbursement, pharmaceuticals, consumerism, consolidation, technology, and more.
Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.
Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.
Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.
Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.
Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.
Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.
Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.
Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.
Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.
Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.
Managed Healthcare Executive's State of the Industry Survey. Survey findings based on responses from more than 600 healthcare executives.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Payers lean on step therapy, formulary exclusions as IRA reshapes Part D benefit design
2
1,700 sites closed, 77,000 fewer children received PEPFAR-supported treatment after PEPFAR disruption | IAS 2026
3
Anti-VEGF injection costs driven by missed work, travel vs drug costs | ASRS 2026
4
Redemplo cuts triglycerides, pancreatitis risk in severe hypertriglyceridemia
5



























